Ralph T. Doyle

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller et al. · New England Journal of Medicine · 2018 · 3.1K citations

Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study

Michael H. Davidson, Evan A. Stein, Harold Bays et al. · Clinical Therapeutics · 2007 · 386 citations

Obesity, Metabolic Syndrome, Hypertriglyceridemic Patients +9

Effects of Icosapent Ethyl on Total Ischemic Events

Deepak L. Bhatt, Philippe Gabríel Steg, Michael Miller et al. · Journal of the American College of Cardiology · 2019 · 248 citations · Full text

Rationale and design of <scp>REDUCE‐IT</scp>: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Deepak L. Bhatt, Philippe Gabríel Steg, Eliot A. Brinton et al. · Clinical Cardiology · 2017 · 177 citations · Full text

REDUCE-IT USA

Deepak L. Bhatt, Michael Miller, Eliot A. Brinton et al. · Circulation · 2019 · 132 citations · Full text